Abstract
About 30% of human tumours contain a mutation in one of the three ras genes leading to the production of p21ras oncoproteins that are thought to make a major contribution to the transformed phenotype of the tumour1,2. The biochemical mode of action of the ras proteins is unknown but as they bind GTP and GDP and have an intrinsic GTPase activity, they may function like regulatory G proteins3–7 and control cell proliferation by regulating signal transduction pathways at the plasma membrane8–10. It is assumed that an external signal is detected by a membrane molecule (or detector) that stimulates the conversion of p21.GDP to p21.GTP which then interacts with a target molecule (or effector) to generate an internal signal. Recently a cytoplasmic protein, GAP, has been identified that interacts with the ras proteins, dramatically increasing the GTPase activity of normal p21 but not of the oncoproteins11. We report here that GAP appears to interact with p21ras at a site previously identified as the 'effector' site12,13, strongly implicating GAP as the biological target for regulation by p21.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barbacid, M. A. Rev. Biochem. 56, 779–827 (1986).
Paterson, H. et al. Cell 51, 803–812 (1987).
McGrath, J. P., Capon, D. J., Goeddel, D. V. & Levinson, A. D. Nature 319, 644–649 (1984).
Trahey, M. et al. Molec. cell. Biol. 7, 541–544 (1987).
Hall, A. & Self, A. J. biol. Chem. 261, 10963–10965 (1986).
Sweet, R. W. et al. Nature 311, 273–275 (1984).
Hurley, J. B., Simon, M. I., Teplow, D. B., Robishaw, J. D. & Gilman, A. G. Science 226, 860–862 (1984).
Mulcahy, L. S., Smith, M. P. & Stacey, D. W. Nature 313, 241–243 (1985).
Wakelam, M. J. O. et al. Nature 323, 173–176 (1986).
Lacal, J. C. et al. Science 238, 533–535 (1987).
Trahey, M. & McCormick, F. Science 238, 542–545 (1987).
Sigal, I. S., Gibbs, J. B., D'Alonzo, J. S. & Scolnick, E. M. Proc. natn. Acad. Sci. U.S.A. 83, 4725–4729 (1986).
Willumsen, B. M. et al. Molec. cell. Biol 6, 2646–2654 (1986).
McCormick, F. et al. Science 280, 78–82 (1985).
Kaziro, Y. Biochim. biophys. Ada 505, 95–127 (1978).
Buss, J. E. & Sefton, B. M. Molec. cell. Biol. 6, 116–122 (1986).
Muller, J. & Germain, R. J. exp. Med. 164, 1478–1489 (1986).
Gross, M. et al. Molec. cell. Biol. 5, 1015–1024 (1985).
Lowe, D. G. & Goeddel, D. V. Molec. cell. Biol. 7, 2845–2856 (1987).
Lowry, O. H., Rosebrough, N. J., Fair, A. L. & Randall, R. J. J. biol. Chem. 193, 265–275 (1950).
Furth, M. E., Davis, L. J., Fleurdelys, B. & Scolnick, E. M. J. Virol. 43, 294–304 (1982).
Marshall, C. J., Hall, A. & Weiss, R. A. Nature 299, 171–173 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Calés, C., Hancock, J., Marshall, C. et al. The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product. Nature 332, 548–551 (1988). https://doi.org/10.1038/332548a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/332548a0
- Springer Nature Limited
This article is cited by
-
The Future of Molecular Analysis in Melanoma: Diagnostics to Direct Molecularly Targeted Therapy
American Journal of Clinical Dermatology (2016)
-
Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells
Oncogene (2002)
-
Differentiation of neuroblastoma cells by phorbol esters and insulin-like growth factor 1 is associated with induction of retinoic acid receptor β gene expression
Oncogene (1999)
-
Ras-mediated cell proliferation and cell death: some clues from the interleukin-2 receptor system
Apoptosis (1996)
-
Positive and negative modulation of H-ras transforming potential by mutations of phenylalanine-28
Molecular Biology Reports (1996)